PMEF
PRDS

Point72 Middle East FZE’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Point72 Middle East FZE’s Portfolio PRDS Stock Details PRDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-4,501
Closed -$8.15K – 2010
2023
Q2 		$8.15K Buy
+4,501
New +$8.23K ﹤0.01% 1421

Other funds holding PRDS

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Point72 Middle East FZE's PRDS Position: Q3 2023 in Review

Point72 Middle East FZE sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q3 2023, closing a stake of 4,501 shares — an estimated $8.15K sold.

Point72 Middle East FZE first reported a position in PRDS in Q2 2023 and held it in 1 quarter. The position peaked at $8.15K in Q2 2023. 1 fund tracked by Wall St. Rank holds PRDS as of Q3 2023.

  • Point72 Middle East FZE reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 4,501 Pardes Biosciences, Inc. Common Stock shares in Q3 2023, an estimated $8.15K.
  • Point72 Middle East FZE first reported a position in Pardes Biosciences, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Point72 Middle East FZE's Pardes Biosciences, Inc. Common Stock position peaked at $8.15K in Q2 2023.
  • 1 fund tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q3 2023.

Based on Point72 Middle East FZE's 13F filing for Q3 2023, filed 14 Nov 2023.